Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (1): 105-114     DOI: 10.31083/j.rcm.2021.01.272
Special Issue: Utilizing Technology in the COVID 19 era
Review Previous articles | Next articles
Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review
Sakine Satici1, Pupalan Iyngkaran2, Sharon Andrew1, Arun Patil3, Niranjan Bidargaddi4, Malcolm Battersby5, Maximilian De Courten1, *()
1Victoria University, PO Box 14428 Melbourne Victoria 8001, Melbourne, Australia
2University of Notre Dame, Werribee Mercy Sub School, School of Medicine Sydney, 300 Princes Hwy, Werribee VIC 3030, Australia
3Academic Dean, Victorian Institute of Technology, Level 14, 123 Queen Street, Melbourne, Victoria 3000, Australia
4Flinders University & SAHMRI, Sturt Rd, Bedford Park SA 5042, Australia
5Professor and Head of Psychiatry, College of Medicine and Public Health, Flinders University, Flinders Medical Centre, Fli nders Drive, Bedford Park SA 5042 GPO Box 2100, Adelaide SA 5001, Australia
Download:  PDF(1299KB)  ( 797 ) Full text   ( 42 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Heart Failure (HF), a common chronic disease, requires multidisciplinary care to optimise outcomes. The COVID-19 pandemic, its impact on people's movement and access to health services, introduced severe challenges to chronic disease management. The era that will evolve after this pandemic is likely to provide uncertainty and service model disruptions. HF treatment is based on guidelines derived from randomised clinical trial evidence. Translational shortfalls from trials into practice have been overcome with post-trial service improvement studies like OPTIMIZE-HF where a team using a process of care can translate evidence to the general population. However, gaps remain for vulnerable populations e.g. those with more severe HF, with multiple comorbid conditions, and certain demographic groups and/or residents in remote locations. Health technology has come with great promise, to fill some of these gaps. The COVID-19 pandemic provides an opportunity to observe, from Australian healthcare lens, HF management outside the traditional model of care. This narrative review describes relatively recent events with health technology as a solution to improve on service gaps.
Key words:  Congestive heart failure      Chronic disease management      Heart failure      Self-management      Health hubs      Health technology     
Submitted:  04 December 2020      Revised:  04 March 2021      Accepted:  04 March 2021      Published:  30 March 2021     
*Corresponding Author(s):  Maximilian De Courten     E-mail:  maximilian.decourten@vu.edu.au

Cite this article: 

Sakine Satici, Pupalan Iyngkaran, Sharon Andrew, Arun Patil, Niranjan Bidargaddi, Malcolm Battersby, Maximilian De Courten. Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review. Reviews in Cardiovascular Medicine, 2021, 22(1): 105-114.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2021.01.272     OR     https://rcm.imrpress.com/EN/Y2021/V22/I1/105

[1] Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, Claudio Ronco. Cardionephrology and cardiorenal disease in Italy: state of the art[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 563-572.
[2] Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 573-584.
[3] Ronald O. Morales, Francesc Barbosa, Nuria Farre. Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 649-657.
[4] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[5] Sarah Fitzsimons, Robert N Doughty. Role of transthoracic echocardiogram in acute heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 741-754.
[6] Martha Kyriakou, Anastasia Samara, Katerina Philippou, Ioanna Lakatamitou, Ekaterini Lambrinou. A qualitative meta-synthesis of patients with heart failure perceived needs[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 853-864.
[7] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[8] Ali Yazdanyar, Muhammad Haisum Maqsood, Jerald Pelayo, Julien Sanon, Eduardo Quintero, Kevin Bryan Lo, Roy O. Mathew, Janani Rangaswami. Clinical outcomes in patients with heart failure with and without cirrhosis: an analysis from the national inpatient sample[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 925-929.
[9] Janani Rangaswami. Closing gaps in the care of patients with heart-kidney disease: the time is now[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 257-258.
[10] Melanie McGinlay, Sam Straw, Jacob Jagger, Bako Nouri, John Gierula, Klaus K Witte. Impact of the COVID-19 pandemic on the management of chronic heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 271-276.
[11] Agata Bielecka-Dabrowa, Anna Cichocka-Radwan, Joanna Lewek, Filip Pawliczak, Marek Maciejewski, Maciej Banach. Cardiac manifestations of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 365-371.
[12] Paulino Alvarez, Alex Sianis, Jessica Brown, Abbas Ali, Alexandros Briasoulis. Chronic disease management in heart failure: focus on telemedicine and remote monitoring[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 403-413.
[13] Catrin Sohrabi, Syed Ahsan, Alexandros Briasoulis, Emmanuel Androulakis, Gerasimos Siasos, Neil T Srinivasan, Nikolaos Papageorgiou. Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 415-428.
[14] Mohd Aizuddin Mohd Zulastri, Muhammad Imran Hafidz, Muhammad Dzafir Ismail, Ahmad Syadi Mahmood Zuhdi. Hematocrit change as a predictor of readmission for decompensated heart failure: a retrospective single centre study[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 505-512.
[15] Martin A. Chacon-Portillo, Tushar Acharya, Rajesh Janardhanan. Imaging in heart failure with preserved ejection fraction: insights into echocardiography and cardiac magnetic resonance imaging[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 11-24.
No Suggested Reading articles found!